Idiopathic pulmonary fibrosis (IPF) is a type of chronic lung disease characterized by a progressive and irreversible decline in lung function.
Aragen Bioscience has a portfolio of in vivo fibrosis models, we offer customised and high quality animal models with ex vivo readouts to support our clients anti-fibrosis drug development.
Download our whitepaper which highlights three case studies:
- Differential Analysis of Infiltrating Leukocytes from BAL Harvest plus Changes in Histology
- Changes in Lung Function in Bleomycin-Induced IPF
- Efficacy of a Small Molecule Compound in Bleomycin-Induced IPF